|
December 12, 2017 0:30 FDA approves Admelog, the first short-acting "follow-on" insulin product to treat diabetes https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm588466.htm http://www.news.sanofi.us/2017-12-11-FDA-Approves-Sanofis-Admelog-R-insulin-lispro-injection 2:48 FDA approves Vercise™ Deep Brain Stimulation System for Parkinsons http://news.bostonscientific.com/2017-12-11-Boston-Scientific-Receives-U-S-FDA-Approval-for-the-Vercise-TM-Deep-Brain-Stimulation-System 5:07 FDA launches public education campaign to encourage adult smokers trying to quit cigarettes https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm588116.htm 8:01 FDA approves Sunuva sinus implant for recurrent nasal polyps https://www.intersectent.com/wp-content/uploads/SINUVA-FDA-Approval-Press-Release-FINAL.pdf 10:30 FDA accepts sBLA and assigns priority review to pembrolizumab for treatment of R/R PMBCL. http://www.mrknewsroom.com/news-release/oncology-newsroom/fda-accepts-supplemental-biologics-license-application-sbla-assigns-p ---- NASCENT MEDICAL Nascent Medical, LLC, has a team of over 100 PhD-/MD-level writers who can write about any medical, scientific or technical topic. They do the following types of writing, including but not limited to: -Video and virtual reality script writing -eLearning scripts -Medical education -Webinar slide creation -Manuscripts -Slidesets -Manuscripts -Press releases -Blog posts -Annual reports -Proposals -White papers -Web content -Posters -Sales training materials contact info@nascentmc.com |